Validation of Arterio Venous Access Stage (AVAS) Classification

NCT04796558 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 800

Last updated 2024-03-29

No results posted yet for this study

Summary

VAVASC trial is an observational multicentre study. The aim of this trial is to validate AVAS (arteriovenous vascular access stage) classification. The classification is used for determining which type of access is the most suitable for the patient on the basis of the patient´s vascular anatomy

The methodology of this trial is to apply AVAS classification on patients who are indicated for creation of vascular access for hemodialysis. Data on these patients (vascular anatomy status, AVAS type, and predicted type of arterio venous access, demographic data etc.) will be than statistically analysed. Patients will then undergo creation of the selected arteriovenous access. They will be observed in terms of the access functionality. The follow up will be 1 to 3 years. The second aim of this study is to evaluate the relationship between AVAS classification and uninterrupted use of the created arterio venous access.

Conditions

  • Arteriovenous Graft
  • Arteriovenous Fistula
  • Dialysis Access Malfunction
  • Kidney Failure
  • Dialysis Related Complication

Interventions

OTHER

AVAS Classification

Validation of AVAS classification

Sponsors & Collaborators

  • Belfast Health and Social Care Trust

    collaborator OTHER
  • Vascular surgery, University hospital Královské Vinohrady, Prague

    lead OTHER

Eligibility

Min Age
16 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-04-01
Primary Completion
2024-12-31
Completion
2024-12-31

Countries

  • Czechia

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04796558 on ClinicalTrials.gov